Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

772 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion.
Lago-Hernandez CA, Feldman H, O'Donnell E, Mahal BA, Perez V, Howard S, Rosenthal M, Cheng SC, Nguyen PL, Beard C, D'Amico AV, Sweeney CJ. Lago-Hernandez CA, et al. Among authors: beard c. Ann Oncol. 2015 Jul;26(7):1396-401. doi: 10.1093/annonc/mdv180. Epub 2015 Apr 17. Ann Oncol. 2015. PMID: 25888612 Free PMC article.
Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of > 4-20 ng/ml.
D'Amico AV, Whittington R, Kaplan I, Beard C, Jiroutek M, Malkowicz SB, Wein A, Coleman CN. D'Amico AV, et al. Among authors: beard c. Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1053-8. doi: 10.1016/s0360-3016(96)00633-5. Int J Radiat Oncol Biol Phys. 1997. PMID: 9169812 Free article.
Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTV.
D'Amico AV, Whittington R, Kaplan I, Beard C, Schultz D, Malkowicz SB, Tomaszewski JE, Wein A, Coleman CN. D'Amico AV, et al. Among authors: beard c. Int J Radiat Oncol Biol Phys. 1997 Sep 1;39(2):335-40. doi: 10.1016/s0360-3016(97)00320-9. Int J Radiat Oncol Biol Phys. 1997. PMID: 9308936 Free article.
Calculated prostate carcinoma volume: The optimal predictor of 3-year prostate specific antigen (PSA) failure free survival after surgery or radiation therapy of patients with pretreatment PSA levels of 4-20 nanograms per milliliter.
D'Amico AV, Whittington R, Kaplan I, Beard C, Schultz D, Malkowicz SB, Wein A, Tomaszewski JE, Coleman CN. D'Amico AV, et al. Among authors: beard c. Cancer. 1998 Jan 15;82(2):334-41. doi: 10.1002/(sici)1097-0142(19980115)82:2<342::aid-cncr14>3.0.co;2-z. Cancer. 1998. PMID: 9445191
Calculated prostate cancer volume greater than 4.0 cm3 identifies patients with localized prostate cancer who have a poor prognosis following radical prostatectomy or external-beam radiation therapy.
D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Kaplan I, Beard CJ, Tomaszewski JE, Renshaw AA, Loughlin KR, Richie JP, Wein A. D'Amico AV, et al. Among authors: beard cj. J Clin Oncol. 1998 Sep;16(9):3094-100. doi: 10.1200/JCO.1998.16.9.3094. J Clin Oncol. 1998. PMID: 9738580
Clinical utility of percent-positive prostate biopsies in predicting biochemical outcome after radical prostatectomy or external-beam radiation therapy for patients with clinically localized prostate cancer.
D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Silver B, Henry L, Hurwitz M, Kaplan I, Beard CJ, Tomaszewski JE, Renshaw AA, Wein A, Richie JP. D'Amico AV, et al. Among authors: beard cj. Mol Urol. 2000 Fall;4(3):171-5;discussion 177. Mol Urol. 2000. PMID: 11062371
772 results